Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
enisamium iodide (1 trial)
inactivated influenza vaccine (4 trials)
inactivated covid-19 vaccine (1 trial)
split virion influenza vaccine (1 trial)
gamezumab (1 trial)
live attenuated influenza virus vaccine (Flumist) (2 trials)
rsv/flu-01e (1 trial)
tb/flu-01l (1 trial)
tb/flu-05e vaccine (1 trial)
Tuberculin, Purified Protein Derivative (Tubersol) (1 trial)
Infections (Phase 3)
Influenza, Human (Phase 3)
Influenza in Birds (Phase 1)
Tuberculosis (Phase 1)
Virus Diseases (Phase 3)
Trials (13 total)
Trial APIs (10 total)